SOLICITATION NOTICE
Q -- CareDX AlloMap and AlloSure post heart transplant rejection surveillance tests
- Notice Date
- 10/8/2021 1:08:23 PM
- Notice Type
- Presolicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- 261-NETWORK CONTRACT OFFICE 21 (36C261) MATHER CA 95655 USA
- ZIP Code
- 95655
- Solicitation Number
- 36C26121Q1193
- Response Due
- 10/28/2021 7:00:00 AM
- Archive Date
- 11/12/2021
- Point of Contact
- David Alvarez, Contracting Officer, Phone: (916) 843-2822
- E-Mail Address
-
david.alvarez4@va.gov
(david.alvarez4@va.gov)
- Small Business Set-Aside
- SBA Total Small Business Set-Aside (FAR 19.5)
- Description
- Department of Veterans Affairs (VA) Network Contracting Office (NCO 21) intends to award a sole source, firm fixed price contract to CareDX, Inc. for AlloMap and AlloSure post heart transplant rejection surveillance tests. CareDX, Inc. performs�specialized genetic blood testing on veteran patients who have undergone heart transplant surgery. The FDA approved tests determine if a heart transplant patient has a stable transplant and is not rejecting the new heart.�The proposed contract will be for the VA Palo Alto Health Care System (VAPAHCS) to obtain the services�for eligible veterans. The solicitation for this action will be posted to SAM.gov, and all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. After consideration, the Government will determine whether to proceed with the sole source acquisition. The solicitation will be posted on or about October�8, 2021.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/9f81139e1d514ec8a3986bc716303297/view)
- Place of Performance
- Address: Palo Alto, CA 94304, USA
- Zip Code: 94304
- Country: USA
- Zip Code: 94304
- Record
- SN06154635-F 20211010/211008230110 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |